| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 01/23/2013 | CN102892766A Kinase inhibitors and method of treating cancer with same |
| 01/23/2013 | CN102892761A 4 - aminopyrimidine derivatives and their as as adenosine a2a receptor antagonists |
| 01/23/2013 | CN102892759A Nitrogen-containing heterocyclic compound having kynurenine production inhibitory activity |
| 01/23/2013 | CN102892758A Pyridine and pyrazine derivative for the treatment of cf |
| 01/23/2013 | CN102887891A N4-phenyl-quinaz0line-4 -amine derivatives and related compounds |
| 01/23/2013 | CN102887890A Synthesis method of candesartan cilexetil |
| 01/23/2013 | CN102887889A Heterocyclic substitute dpyrimidines |
| 01/23/2013 | CN102887859A Compound having analgesic and anti-inflammatory activity, preparation method thereof and application thereof |
| 01/23/2013 | CN101490017B Therapeutic piperazines as pde4 inhibitors |
| 01/22/2013 | US8357689 Substituted arylsulfonylaminomethylphosphonic acid derivatives, their preparation and their use in the treatment of type I and II diabetes mellitus |
| 01/22/2013 | US8357686 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament |
| 01/22/2013 | US8357679 Hexafluoroisopropanol derivatives |
| 01/22/2013 | US8357673 4-arylazo-3,5-diamino-pyrazole compounds and use thereof |
| 01/22/2013 | CA2672271C Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
| 01/22/2013 | CA2565695C Certain chemical entities and compositions for use in the treatment of a cellular proliferative disease or disorder |
| 01/17/2013 | WO2013008002A1 N- (6- ( (2r,3s) -3,4-dihydroxybutan-2-yloxy) -2- (4 - fluorobenzylthio) pyrimidin- 4 - yl) -3- methylazetidine- 1 - sulfonamide as chemokine receptor modulator |
| 01/17/2013 | WO2013007502A1 Substituted phenyl compounds |
| 01/17/2013 | WO2013007184A1 Antineoplastic drug tetrahydronaphthalene amide-group compound and pharmaceutically acceptable salt, preparation method and use thereof |
| 01/17/2013 | WO2013007106A1 Spiro compounds as hepatitis c virus inhibitors |
| 01/17/2013 | WO2012135697A3 Novel rho kinase inhibitors and methods of use |
| 01/17/2013 | WO2012068234A3 Antiviral compounds |
| 01/17/2013 | US20130018184 Methods of preparing polymorphic form a of bazedoxifene acetate |
| 01/17/2013 | US20130018053 Substituted pyrimidines |
| 01/17/2013 | US20130018051 Bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 01/17/2013 | US20130018046 Acetylenic Heteroaryl Compounds |
| 01/17/2013 | US20130018039 Imidazolyl-imidazoles as kinase inhibitors |
| 01/17/2013 | US20130018038 Chemical compounds |
| 01/17/2013 | US20130018033 Raf inhibitor compounds and methods of use thereof |
| 01/17/2013 | US20130018031 Aminoalkylpyrimidine derivatives as histamine h4 receptor antagonists |
| 01/17/2013 | US20130017196 Substituted imidazole derivatives |
| 01/17/2013 | US20130017194 Fak inhibitors |
| 01/17/2013 | US20130015403 Compounds for electronic devices |
| 01/17/2013 | CA2841859A1 N- (6- ( (2r,3s) -3,4-dihydroxybutan-2-yloxy) -2- (4 - fluorobenzylthio)pyrimidin- 4 - yl) -3- methylazetidine- 1 - sulfonamide as chemokine receptor modulator |
| 01/17/2013 | CA2841095A1 Spiro compounds as hepatitis c virus inhibitors |
| 01/17/2013 | CA2837150A1 Substituted phenyl compounds |
| 01/16/2013 | EP2546253A1 Substituted dihydropyrazolones for the treatment of cardiovascular and hematological diseases |
| 01/16/2013 | EP2546232A1 Diphenyl Substituted Alkanes |
| 01/16/2013 | EP2545058A2 Heterocyclic inhibitors of histamine receptors for the treatment of disease |
| 01/16/2013 | EP2545047A1 Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5) |
| 01/16/2013 | EP2545046A1 N-acyl cyclic amine derivative or pharmaceutically acceptable salt thereof |
| 01/16/2013 | EP2545042A1 Compounds for the treatment of hepatitis c |
| 01/16/2013 | EP2545039A1 A process for making voriconazole |
| 01/16/2013 | EP2281822B1 New dihydroindolone derivatives, method of preparing same and pharmaceutical compositions containing them |
| 01/16/2013 | CN102884156A Light-emitting device material and light-emitting device |
| 01/16/2013 | CN102884060A Heterocyclic compounds useful for kinase inhibition |
| 01/16/2013 | CN102884059A N-酰基环胺衍生物或其可药用盐 N- acyl cyclic amine derivative or pharmaceutically acceptable salt thereof |
| 01/16/2013 | CN102884054A Fluoroalkyl-substituted 2-amidobenzimidazoles and the use thereof for boosting stress tolerance in plants |
| 01/16/2013 | CN102884052A Oxygen-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals |
| 01/16/2013 | CN102884048A Amino-heteroaryl derivatives as HCN blockers |
| 01/16/2013 | CN102884045A Succinimide compound, lubricating oil additive, and lubricating oil composition |
| 01/16/2013 | CN102884044A Derivatives of aminoindanes, their preparation and their application in therapeutics |
| 01/16/2013 | CN102883718A Analogues for the treatment or prevention of flavivirus infections |
| 01/16/2013 | CN102883606A Hydrazine-substituted anthranilic acid derivatives |
| 01/16/2013 | CN102875535A 1,5-[(substituted)-methano]-tetrahydro-1H-pyrrole[1,2-c]-imidazole-3(2H)-ketone derivative and preparation method thereof |
| 01/16/2013 | CN102875534A Synthetic method of irbesartan |
| 01/16/2013 | CN102872018A Tyrosine kinase irreversible inhibitor and preparation method and applications thereof |
| 01/16/2013 | CN101921236B 2, 4- di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 01/16/2013 | CN101747253B Trisubstituted chiral lactam derivative and preparation method and application thereof |
| 01/16/2013 | CN101405270B Pyrazoles as 11-beta-HSD-1 |
| 01/15/2013 | US8354545 3,4-substituted pyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease |
| 01/15/2013 | US8354535 Salts of 6-heterocycle substituted hexahydrophenanthridine derivatives |
| 01/15/2013 | US8354442 Imidazol-4-one and imidazole-4-thione compounds |
| 01/15/2013 | US8354440 3-3-di-substituted-oxindoles as inhibitors of translation initiation |
| 01/15/2013 | US8354434 Cyclourea compounds as calcium channel blockers |
| 01/15/2013 | US8354422 Pyrimidine inhibitors of kinase activity |
| 01/15/2013 | US8354419 Benzimidazole analogues for the treatment or prevention of flavivirus infections |
| 01/15/2013 | US8354399 Substituted indazole derivatives active as kinase inhibitors |
| 01/15/2013 | CA2702834C Substituted n-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof |
| 01/15/2013 | CA2572971C Substituted propenyl piperazine derivatives as novel inhibitors of histone deacetylase |
| 01/15/2013 | CA2547391C Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament |
| 01/10/2013 | WO2013006738A1 Compounds for the treatment of hiv |
| 01/10/2013 | WO2013006485A1 Fused benzoxazepinones as ion channel modulators |
| 01/10/2013 | WO2013006308A2 Dihydropyrazoles |
| 01/10/2013 | WO2013005798A1 Novel nitrogenated heterocyclic ring derivative |
| 01/10/2013 | WO2013004709A1 Indolylmaleimides as soft pan-pkc inhibitors |
| 01/10/2013 | WO2012112674A3 Compounds and methods of use thereof for treating neurodegenerative disorders |
| 01/10/2013 | WO2012101065A3 Pyrimidine biaryl amine compounds and their use as cdk9 inhibitors |
| 01/10/2013 | WO2012075287A3 Novel selective inhibitors of prolylcarboxypeptidase |
| 01/10/2013 | US20130012709 NOVEL INHIBITORS OF STEAROYL-CoA-DESATURASE-1 AND THEIR USES |
| 01/10/2013 | US20130012708 Heterocyclic compounds and thrombopoietin receptor activators |
| 01/10/2013 | US20130012705 Dicycloazaalkane derivatives, preparation processes and medical uses thereof |
| 01/10/2013 | US20130012704 Compounds and compositions as protein kinase inhibitors |
| 01/10/2013 | US20130012702 Purification of progesterone receptor modulators |
| 01/10/2013 | US20130012620 Curing agents for epoxy resins |
| 01/10/2013 | US20130012564 SMAC Mimetic |
| 01/10/2013 | US20130012540 Hepatitis C Virus Inhibitors |
| 01/10/2013 | US20130012532 Cyclopropanecarboxylic acid derivative |
| 01/10/2013 | US20130012522 New derivatives of propargylamine having neuroprotective capacity for the treatment of alzheimer's and parkinson's diseases |
| 01/10/2013 | US20130012512 P38 MAP kinase inhibitors |
| 01/10/2013 | US20130012511 Soluble guanylate cyclase activators |
| 01/10/2013 | US20130012503 Metalloenzyme inhibitor compounds |
| 01/10/2013 | US20130012500 Organic compounds |
| 01/10/2013 | US20130012498 5ht2c receptor modulators |
| 01/10/2013 | US20130012495 5ht2c receptor modulators |
| 01/10/2013 | US20130012493 Novel spiro imidazolone derivatives as glucagon receptor antagonists, compositions, and methods for their use |
| 01/10/2013 | US20130012492 Fused heterocyclic compounds as ion channel modulators |
| 01/10/2013 | US20130012491 Pyrimidine derivatives for use as sphingosine 1-phosphate 1 (s1p1) receptor agonists |
| 01/10/2013 | US20130012490 Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators |
| 01/10/2013 | US20130012434 Novel spiro imidazolones as glucagon receptor antagonists, compositions, and methods for their use |
| 01/10/2013 | US20130012382 Pyridazine Compounds for Controlling Invertebrate Pests |